Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma

被引：0
|
作者：
S Lee
Y H Park
K H Kim
E Y Cho
Y C Ahn
K Kim
Y-M Shim
J S Ahn
K Park
Y-H Im
机构：
[1] Samsung Medical Center,Division of Hematology
[2] Sungkyunkwan University School of Medicine,Oncology, Department of Medicine
[3] Samsung Medical Center,Department of Pathology
[4] Sungkyunkwan University School of Medicine,Department of Radiation Oncology
[5] Samsung Medical Center,Department of Thoracic Surgery
[6] Sungkyunkwan University School of Medicine,undefined
[7] Samsung Medical Center,undefined
[8] Sungkyunkwan University School of Medicine,undefined
来源：
British Journal of Cancer | 2010年 / 103卷
关键词：
oesophageal cancer; capecitabine; cisplatin; thymidine synthase (TS); thymidine phosphorylase (TP); excesion repair cross-complementation group 1 (ERCC1);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：845 / 851
页数：6
相关论文
共 50 条
  • [1] Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma
    Lee, S.
    Park, Y. H.
    Kim, K. H.
    Cho, E. Y.
    Ahn, Y. C.
    Kim, K.
    Shim, Y-M
    Ahn, J. S.
    Park, K.
    Im, Y-H
    BRITISH JOURNAL OF CANCER, 2010, 103 (06) : 845 - 851
  • [2] Excision repair cross-complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin-based chemotherapy
    Kim, Kyoung Ha
    Do, In-Gu
    Kim, Hyeong Su
    Chang, Myung Hee
    Kim, Hyo Song
    Jun, Hyun Jung
    Uhm, Jieun
    Yi, Seong Yoon
    Lim, Do Hyoung
    Ji, Sang Hoon
    Park, Min Jae
    Lee, Jeeyun
    Park, Se Hoon
    Kwon, Ghee Young
    Lim, Ho Yeong
    APMIS, 2010, 118 (12) : 941 - 948
  • [3] Expression of excision repair cross-complementation group 1 in locoregionally advanced nasopharyngeal carcinoma treated with cisplatin-based induction chemotherapy
    Shen, Chuan
    Chen, Lingling
    Fu, Jiangtao
    Lin, Hongbin
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (05) : 72 - 75
  • [4] Expressions of Thymidylate Synthase, Thymidine Phosphorylase, Class Ⅲ β-tubulin, and Excision Repair Cross-complementing Group 1 Predict Response in Advanced Gastric Cancer Patients Receiving Capecitabine Plus Paclitaxel or Cisplatin
    Ming Lu
    ChineseJournalofCancerResearch, 2011, 23 (04) : 288 - 294
  • [5] Excision Repair Cross-Complementation Group 1 (ERCC1) Expression in Advanced Urothelial Carcinoma Patients Receiving Cisplatin-Based Chemotherapy Editorial Comment
    Wood, David P.
    JOURNAL OF UROLOGY, 2011, 186 (03): : 842 - 842
  • [6] Expressions of thymidylate synthase, thymidine phosphorylase, class III β-tubulin, and excision repair cross-complementing group 1 predict response in advanced gastric cancer patients receiving capecitabine plus paclitaxel or cisplatin
    Lu, Ming
    Gao, Jing
    Wang, Xi-cheng
    Shen, Lin
    CHINESE JOURNAL OF CANCER RESEARCH, 2011, 23 (04) : 288 - 294
  • [7] Predictive value of excision repair cross-complementation group 1 expression in locoregionally advanced nasopharyngeal carcinoma receiving cisplatin-based concurrent chemoradiotherapy
    Wang, Dong
    Zhou, Juan
    Zheng, Jihua
    Zhang, Jiang
    Chen, Yaoming
    Li, Wen
    Wang, Ruizhi
    CANCER BIOMARKERS, 2018, 21 (04) : 875 - 881
  • [8] Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination Chemotherapy
    Kim, Miso
    Ku, Ja Hyeon
    Kwak, Cheol
    Kim, Hyeon Hoe
    Lee, Eunsik
    Keam, Bhumsuk
    Kim, Tae Min
    Heo, Dae Seog
    Lee, Se-Hoon
    Moon, Kyung Chul
    PLOS ONE, 2015, 10 (07):
  • [9] Prognostic and Predictive Role of Excision Repair Cross-complementation Group 1 and Thymidylate Synthase in Colorectal Carcinoma Patients Received FOLFOX Chemotherapy: An Immunohistochemical Study
    Badary, Dalia M.
    Elkabsh, Mai M.
    Mady, Hussam H.
    Gabr, Adel
    Kroosh, Sana S.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (10) : 741 - 747
  • [10] Anti-PD1 antibodies plus chemotherapy for first-line treatment of advanced oesophageal squamous cell carcinoma
    Qian, J.
    Lin, W.
    Wang, H.
    Du, X.
    Wu, M.
    Huang, Y.
    Xu, N.
    Teng, L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1749 - 1749
12345